IE
VNDA icon

Israel Englander’s Vanda Pharmaceuticals VNDA Stock Holding History

Israel Englander’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50,100
Closed -$250K – 6501
2025
Q3 		$250K Buy
+50,100
New +$232K ﹤0.01% 5433
2014
Q1 		– Sell
-135,900
Closed -$1.69M – 3915
2013
Q4 		$1.69M Sell
135,900
-26,900
-17% -$270K 0.01% 1942
2013
Q3 		$1.78M Buy
162,800
+102,600
+170% +$1.1M 0.01% 1755
2013
Q2 		$486K Buy
+60,200
New +$405K ﹤0.01% 2355

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Israel Englander's VNDA Position: Q2 2026 in Review

Israel Englander reduced its Vanda Pharmaceuticals (VNDA) stake by 15% in Q2 2026, selling an estimated $1.82M and leaving 1,602,813 shares worth $9.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

Israel Englander first reported a position in VNDA in Q2 2013 and has held it in 52 quarters since. The position peaked at $28M in Q3 2016. 171 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Israel Englander held 1,602,813 shares of Vanda Pharmaceuticals worth $9.81M as of Q2 2026.
  • Israel Englander sold 278,188 Vanda Pharmaceuticals shares in Q2 2026, an estimated $1.82M.
  • Vanda Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2298 holding.
  • Israel Englander first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Israel Englander's Vanda Pharmaceuticals position peaked at $28M in Q3 2016.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.